ubiquinone has been researched along with ascofuranone* in 2 studies
2 other study(ies) available for ubiquinone and ascofuranone
Article | Year |
---|---|
Purification and kinetic characterization of recombinant alternative oxidase from Trypanosoma brucei brucei.
The trypanosome alternative oxidase (TAO) functions in the African trypanosomes as a cytochrome-independent terminal oxidase, which is essential for their survival in the mammalian host and as it does not exist in the mammalian host is considered to be a promising drug target for the treatment of trypanosomiasis. In the present study, recombinant TAO (rTAO) overexpressed in a haem-deficient Escherichia coli strain has been solubilized from E. coli membranes and purified to homogeneity in a stable and highly active form. Analysis of bound iron detected by inductively coupled plasma-mass spectrometer (ICP-MS) reveals a stoichiometry of two bound iron atoms per monomer of rTAO. Confirmation that the rTAO was indeed a diiron protein was obtained by EPR analysis which revealed a signal, in the reduced forms of rTAO, with a g-value of 15. The kinetics of ubiquiol-1 oxidation by purified rTAO showed typical Michaelis-Menten kinetics (K(m) of 338microM and V(max) of 601micromol/min/mg), whereas ubiquinol-2 oxidation showed unusual substrate inhibition. The specific inhibitor, ascofuranone, inhibited the enzyme in a mixed-type inhibition manner with respect to ubiquinol-1. Topics: Catalysis; Electron Spin Resonance Spectroscopy; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Escherichia coli; Kinetics; Mass Spectrometry; Mitochondrial Proteins; Oxidation-Reduction; Oxidoreductases; Plant Proteins; Protozoan Proteins; Recombinant Proteins; Sesquiterpenes; Substrate Specificity; Trypanosoma brucei brucei; Ubiquinone | 2010 |
An antibiotic, ascofuranone, specifically inhibits respiration and in vitro growth of long slender bloodstream forms of Trypanosoma brucei brucei.
Ascofuranone, a prenylphenol antibiotic isolated from a phytopathogenic fungus, Ascochyta visiae, strongly inhibited both glucose-dependent cellular respiration and glycerol-3-phosphate-dependent mitochondrial O2 consumption of long slender bloodstream forms of Trypanosoma brucei brucei. This inhibition was suggested to be due to inhibition of the mitochondrial electron-transport system, composed of glycerol-3-phosphate dehydrogenase (EC 1.1.99.5) and plant-like alternative oxidase. Ascofuranone noncompetitively inhibited the reduced coenzyme Q1-dependent O2 uptake of the mitochondria with respect to ubiquinol (Ki = 2.38 nM). Therefore, the susceptible site is deduced to be the ubiquinone redox machinery which links the two enzyme activities. Further, ascofuranone in combination with glycerol completely blocked energy production, and potently inhibited the in vitro growth of the parasite. Our findings suggest that ascofuranone might be a promising candidate for the chemotherapeutic agents of African trypanosomiasis. Topics: Animals; Anti-Bacterial Agents; Electron Transport; Energy Metabolism; Glucose; Glycerol; Glycerophosphates; In Vitro Techniques; Male; Mice; Mitochondria; Oxidation-Reduction; Oxygen Consumption; Rats; Rats, Wistar; Sesquiterpenes; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African; Ubiquinone | 1997 |